FAST FUNDING FOR SCIENTISTS
We are dedicated to accelerating innovation and advancing science for most neglected populations. That’s why we want to catalyze research in an open innovation spirit as well as reduce the financial hurdles. We have invited pre-clinical researchers in the field of schistosomiasis to apply to our fast-funding program: the SCHISTOSOMIASIS RESEARCH GRANT Initiative. The Call for Proposal closed on October 31, 2021.
WHO DID APPLY AND WIN?
Pre-clinical researchers in the field of schistosomiasis applied mainly from endemic and/or low- and middle-income countries.
Over 200 expression of interests and about 100 applications have been received and evaluated by our Selection Committee.
As a leading Science & Technology Company, we are proud to enable the application of science to the most neglected diseases! With our Schistosomiasis Research Grant initiative, we aim to catalyze home grown innovation and utilize local scientific know-how to address critical unmet medical needs of vulnerable populations.
15 projects have been selected considering a holistic approach spanning from drug resistance, drug discovery, immunology, diagnostics and vector surveillance. Winners benefit from financial support in the form of a grant of 30,000 Euro. They also keep all rights to results and their respective IP.
This initiative will generate tangible data: it will advance research and development for innovative treatments, sensitive diagnostics and local scientific know-how mainly in Africa in line with our integrated strategy and approach towards schistosomiasis elimination.
List of Winners
contact us
Contact us at globalhealth@emdgroup.com